Results 41 to 50 of about 10,634 (236)

A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen   +14 more
wiley   +1 more source

Malignant pleural mesothelioma with constrictive pericarditis as the first manifestation: A case report

open access: yesClinical Case Reports, 2023
Pleural mesothelioma (PM) with pericardial involvement is extremely rare. We now report a rare case of malignant PM with constrictive pericarditis as the first presentation.
Cheng‐Peng He   +10 more
doaj   +1 more source

Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies [PDF]

open access: yes, 2008
FUNDAMENTO: O NT pro-BNP é marcador de disfunção sistólica e diastólica. OBJETIVO: Determinar os níveis de NT pro-BNP em pacientes com cardiopatia chagásica, hipertrófica, restritiva e afecções pericárdicas, e sua relação com medidas ecocardiográficas de
ARTEAGA, Edmundo   +8 more
core   +2 more sources

Effusive-Constrictive Pericarditis

open access: yesJournal of the American College of Cardiology, 2010
![Figure][1] A 15-year-old boy developed cough, low-grade fever, and extreme lethargy over 4 weeks that was unresponsive to a short course of macrolide antibiotic. Laboratory workup was notable for a negative Epstein-Barr virus early antigens antibody, monoslide test, and normal ...
Andrew O. Zurick, Allan L. Klein
openaire   +3 more sources

Harnessing chimeric antigen receptor macrophages against solid tumors

open access: yesCancer Communications, EarlyView.
Abstract Macrophages are prevalent in multiple tumors and exhibit diverse and potent functional activities. Therapeutic reprogramming of macrophage phenotypes represents a promising strategy for cancer immunotherapy. Engineering chimeric antigen receptors (CARs) to endow macrophages with anti‐tumor capacities demonstrated encouraging efficacy ...
Mengru Wang   +3 more
wiley   +1 more source

Delayed Diagnosis of Constrictive Pericarditis Resulting in Recurrent Heart Failure: A Case Report

open access: yesClinical Medicine Insights: Case Reports
Constrictive pericarditis can lead to compromised diastolic ventricular filling due to pericardial inflammation and fibrosis. A diagnosis of constrictive pericarditis was established by identifying structural and hemodynamic features through ...
Chunliang Wang   +5 more
doaj   +1 more source

Chronic constrictive pericarditis: a rare cardiac involvement in primary Sjögren’s syndrome

open access: yesBMC Cardiovascular Disorders, 2023
Background Constrictive pericarditis represents a chronic condition and systemic inflammatory diseases are a known, yet uncommon, cause. Pericardial involvement is seldom reported in primary Sjögren’s syndrome, usually occurring in association with ...
Fabiana Duarte   +5 more
doaj   +1 more source

Constrictive Pericarditis with Extensive Calcification and Caseous Necrosis [PDF]

open access: yesBrazilian Journal of Cardiovascular Surgery, 2020
Constrictive pericarditis is a disease where loss of pericardial elasticity and restriction of filling of the cardiac chambers occurs. It is most often seen as an associated symptom of heart failure.
Marco Antônio Volpe   +5 more
doaj   +1 more source

ETIOLOGY, INVESTIGATIONS, AND TREATMENT IN CASES OF CONSTRICTIVE PERICARDITIS [PDF]

open access: yes, 2022
The fibroelastic sac that covers the heart is known as the pericardium. It has an effect on cardiac hemodynamics and serves as a protective barrier. Constrictive pericarditis is a condition in which the pericardium grows granulation tissue, causing a ...
ABD AL-RAZIK, ASHRAF HAMADA   +5 more
core   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy